Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,726,234
+$58,420 QoQ
Shares Held
6,797
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#2,480
of 4,676 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bull Harbor Capital LLC holds $13,872,560 across 8 Drug Manufacturers - General names. JNJ ranks #4 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
65,358 | $3,765,927 | |
| 2 | MRK |
Merck & Co., Inc.
|
23,810 | $3,059,585 | |
| 3 | LLY |
ELI LILLY & Co
|
2,357 | $2,827,056 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
6,797 | $1,726,234 | |
| 5 | BIIB |
Biogen Inc.
|
6,026 | $1,301,977 | |
| 6 | PFE |
Pfizer Inc
|
28,765 | $692,661 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,164 | $273,399 | |
| 8 | ABBV |
AbbVie Inc.
|
897 | $225,721 |
All Filings in JNJ
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,726,234 | 6,797 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,667,814 | 6,823 | Shares | Sole | 2026-05-18 | |
| No filing history on record for this holder in this stock. | ||||||